United States · FDA National Drug Code directory
zolmitriptan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-711_670da414-66ad-4c5f-b218-f4958daae12c
- Product NDC
- 45802-711
- Form
- SPRAY
- Composition / generic term
- zolmitriptan
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20211116
- Source listing expiry
- 20261231
Source-listed ingredients
- ZOLMITRIPTAN — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 BOTTLE, SPRAY in 1 CARTON (45802-711-91) / 1 SPRAY in 1 BOTTLE, SPRAY (45802-711-00) · 45802-711-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →